Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

SALT LAKE CITY, Utah. (Ivanhoe Newswire) - Chronic pain and treatment-resistant depression both impact millions of people. Both can be debilitating and both can leave people feeling hopeless, ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

Chronic pain and treatment resistant depression — both impact millions of people, both can be debilitating, and both can leave people feeling hopeless, impacting daily activities, relationships, and ...

The United States Food and Drug Administration cleared the investigational new drug application for VLS-01 (buccal film DMT); ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

In a breakthrough study, researchers from the National University of Singapore (NUS) have developed a new way to deliver ...

Acupuncture. Ketamine infusions. “Electroshock” or electroconvulsive therapy. The existing treatment options for those ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...